JP2018513188A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513188A5 JP2018513188A5 JP2017555494A JP2017555494A JP2018513188A5 JP 2018513188 A5 JP2018513188 A5 JP 2018513188A5 JP 2017555494 A JP2017555494 A JP 2017555494A JP 2017555494 A JP2017555494 A JP 2017555494A JP 2018513188 A5 JP2018513188 A5 JP 2018513188A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- meropenem
- pharmaceutically acceptable
- acceptable salt
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 17
- 150000001875 compounds Chemical class 0.000 claims 16
- DMJNNHOOLUXYBV-PQTSNVLCSA-N Meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 claims 13
- 229960002260 meropenem Drugs 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 13
- 239000011780 sodium chloride Substances 0.000 claims 13
- 230000037250 Clearance Effects 0.000 claims 4
- 229940109239 Creatinine Drugs 0.000 claims 4
- 230000035512 clearance Effects 0.000 claims 4
- 229940000425 combination drugs Drugs 0.000 claims 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims 4
- 206010060945 Bacterial infection Diseases 0.000 claims 3
- 230000002730 additional Effects 0.000 claims 3
- 238000001802 infusion Methods 0.000 claims 3
- 238000001990 intravenous administration Methods 0.000 claims 3
- 241000588921 Enterobacteriaceae Species 0.000 claims 1
- 206010024971 Lower respiratory tract infection Diseases 0.000 claims 1
- 206010062237 Renal impairment Diseases 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agents Drugs 0.000 claims 1
- 239000000043 antiallergic agent Substances 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 231100000857 poor renal function Toxicity 0.000 claims 1
- IOOWNWLVCOUUEX-WPRPVWTQSA-N OB1O[C@H](CC(O)=O)CC[C@@H]1NC(Cc1ccc[s]1)=O Chemical compound OB1O[C@H](CC(O)=O)CC[C@@H]1NC(Cc1ccc[s]1)=O IOOWNWLVCOUUEX-WPRPVWTQSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021101472A JP7245289B2 (ja) | 2015-04-24 | 2021-06-18 | 細菌感染症の処置方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562152668P | 2015-04-24 | 2015-04-24 | |
| US62/152,668 | 2015-04-24 | ||
| PCT/US2016/028437 WO2016172208A1 (en) | 2015-04-24 | 2016-04-20 | Methods of treating bacterial infections |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021101472A Division JP7245289B2 (ja) | 2015-04-24 | 2021-06-18 | 細菌感染症の処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018513188A JP2018513188A (ja) | 2018-05-24 |
| JP2018513188A5 true JP2018513188A5 (US06780888-20040824-C00057.png) | 2019-05-30 |
| JP6945452B2 JP6945452B2 (ja) | 2021-10-06 |
Family
ID=57144340
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555494A Active JP6945452B2 (ja) | 2015-04-24 | 2016-04-20 | 細菌感染症の処置方法 |
| JP2021101472A Active JP7245289B2 (ja) | 2015-04-24 | 2021-06-18 | 細菌感染症の処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021101472A Active JP7245289B2 (ja) | 2015-04-24 | 2021-06-18 | 細菌感染症の処置方法 |
Country Status (9)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2691468T3 (es) | 2010-08-10 | 2018-11-27 | Rempex Pharmaceuticals, Inc. | Derivados de éster del ácido borónico cíclicos y usos terapéuticos de los mismos |
| JP2016509594A (ja) | 2013-01-04 | 2016-03-31 | レンペックス・ファーマシューティカルズ・インコーポレイテッド | ボロン酸誘導体及びその治療的使用 |
| DK3140310T3 (da) | 2014-05-05 | 2019-10-21 | Rempex Pharmaceuticals Inc | Syntese af boronatsalte og brug deraf |
| EP3139930A4 (en) | 2014-05-05 | 2018-01-17 | Rempex Pharmaceuticals, Inc. | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof |
| EP3145936B1 (en) | 2014-05-19 | 2020-09-30 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| EP3164406A4 (en) | 2014-07-01 | 2018-04-04 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| WO2016081297A1 (en) | 2014-11-18 | 2016-05-26 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| WO2016149393A1 (en) | 2015-03-17 | 2016-09-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| ES2894251T3 (es) | 2016-06-30 | 2022-02-14 | Qpex Biopharma Inc | Derivados de ácido borónico y usos terapéuticos de los mismos |
| DK3565551T3 (da) | 2017-01-09 | 2024-06-17 | Melinta Therapeutics Inc | Fremgangsmåder til behandling af bakterielle infektioner med en kombination af vaborbactam og meropenem |
| EP3691652A4 (en) | 2017-10-03 | 2021-07-07 | Melinta Therapeutics, Inc. | BACTERIAL INFECTION TREATMENT PROCESSES |
| JP7377545B2 (ja) | 2017-10-11 | 2023-11-10 | キューペックス バイオファーマ， インコーポレイテッド | ボロン酸誘導体およびその合成 |
| CN112424209A (zh) | 2018-04-20 | 2021-02-26 | Qpex生物制药有限公司 | 硼酸衍生物及其治疗用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783443A (en) | 1986-03-03 | 1988-11-08 | The University Of Chicago | Amino acyl cephalosporin derivatives |
| ES2691468T3 (es) | 2010-08-10 | 2018-11-27 | Rempex Pharmaceuticals, Inc. | Derivados de éster del ácido borónico cíclicos y usos terapéuticos de los mismos |
| US10561675B2 (en) * | 2012-06-06 | 2020-02-18 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
-
2016
- 2016-04-20 WO PCT/US2016/028437 patent/WO2016172208A1/en active Application Filing
- 2016-04-20 ES ES16783764T patent/ES2942329T3/es active Active
- 2016-04-20 AU AU2016252555A patent/AU2016252555A1/en not_active Abandoned
- 2016-04-20 US US15/134,198 patent/US20160339045A1/en not_active Abandoned
- 2016-04-20 JP JP2017555494A patent/JP6945452B2/ja active Active
- 2016-04-20 EP EP16783764.0A patent/EP3285776B1/en active Active
- 2016-04-20 CN CN202110100198.0A patent/CN112755039A/zh active Pending
- 2016-04-20 CA CA2982911A patent/CA2982911C/en active Active
- 2016-04-20 CN CN201680023884.XA patent/CN107530364A/zh active Pending
-
2018
- 2018-07-06 US US16/029,388 patent/US20190105337A1/en not_active Abandoned
- 2018-07-12 HK HK18109076.8A patent/HK1249432A1/zh unknown
-
2021
- 2021-06-18 JP JP2021101472A patent/JP7245289B2/ja active Active
